Adding a new indication for the CAR T cell therapy could help BMS offset the loss-of-exclusivity headwinds it faces in the ...

ASH 2024 featured practice-changing studies in lymphoid malignancies, including tafasitamab’s impact in FL, ibrutinib’s OS benefit in MCL, and promising epcoritamab data in CLL.

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

If you need help finding counseling services, call the Leukemia & Lymphoma Society at 800-955-4572. Get quality sleep. Chronic lymphocytic leukemia and its treatments can make you feel tired and ...

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

Panelists discuss how therapy sequencing is approached for patients with chronic lymphocytic leukemia (CLL), with a focus on ...

Living with lymphoma for 15 years, I developed a concerning rash post-vacation, which led to a leukocytoclastic vasculitis ...

Support from family and friends fosters resilience, while poetry can provide profound healing and hope. Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us ...

The lymphatic system is susceptible to various types of lymphomas such as multiple myeloma, chronic lymphocytic leukemia, skin lymphomas, and Hodgkin lymphoma, also known as malignant lymphoma.

The protease mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) is a signaling protein with both molecular scaffolding and protease activity involved in lymphocyte activation. MALT1 is ...

Calquence, an inhibitor of Bruton tyrosine kinase, is also indicated for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. It is supplied as 100mg tablets.